S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

实时更新: Evotec SE [EVT.DE]

交易所: XETRA 部门: Life Sciences Tools & Services 工业: Drug Manufacturers—Specialty & Generic
最后更新时间26 Apr 2024 @ 23:35

0.82% 9.24

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:35):

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health...

Stats
今日成交量 4.26M
平均成交量 1.12M
市值 1.63B
EPS €-0.220 ( 2023-11-08 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -8.97
ATR14 €0.0170 (0.18%)

音量 相关性

長: 0.08 (neutral)
短: -0.63 (weak negative)
Signal:(44.048) Neutral

Evotec SE 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Evotec SE 相关性 - 货币/商品

The country flag -0.17
( neutral )
The country flag -0.32
( neutral )
The country flag 0.00
( neutral )
The country flag -0.15
( neutral )
The country flag 0.00
( neutral )
The country flag 0.18
( neutral )

Evotec SE 财务报表

Annual 2022
营收: €751.45M
毛利润: €174.07M (23.16 %)
EPS: €-0.990
FY 2022
营收: €751.45M
毛利润: €174.07M (23.16 %)
EPS: €-0.990
FY 2021
营收: €618.03M
毛利润: €151.54M (24.52 %)
EPS: €1.300
FY 2020
营收: €500.92M
毛利润: €125.74M (25.10 %)
EPS: €0.0400

Financial Reports:

No articles found.

Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。